Lidia Moreira Lima Selected Research

LASSBIO596

4/2022	LASSBio-596: a New Pre-clinical Candidate for Rheumatoid Arthritis?
1/2018	Lung and liver responses to 1- and 7-day treatments with LASSBio-596 in mice subchronically intoxicated by microcystin-LR.
2/2015	Investigating the therapeutic effects of LASSBio-596 in an in vivo model of cylindrospermopsin-induced lung injury.
1/2012	Potential inhibitory effect of LASSBio-596, a new thalidomide hybrid, on inflammatory corneal angiogenesis in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lidia Moreira Lima Research Topics

Disease

2	Pain (Aches) 04/2022 - 08/2021
2	Wounds and Injuries (Trauma) 04/2022 - 01/2018
1	Arthritis (Polyarthritis) 04/2022
1	Peritonitis 04/2022
1	Edema (Dropsy) 04/2022
1	Cutaneous Leishmaniasis 01/2022
1	Chronic Pain 08/2021
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Asthma (Bronchial Asthma) 10/2020
1	Insulin Resistance 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Lung Injury 02/2015
1	Pulmonary Embolism 01/2013
1	Thromboembolism 01/2013
1	Thrombosis (Thrombus) 01/2013
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2013
1	Corneal Neovascularization 01/2012
1	Neglected Diseases 03/2009
1	Communicable Diseases (Infectious Diseases) 03/2009
1	Schistosomiasis (Bilharziasis) 03/2009

Drug/Important Bio-Agent (IBA)

4	LASSBIO596IBA 04/2022 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2022 - 03/2009
1	Formaldehyde (Formol)FDA Link 04/2022
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2022
1	Glutamic Acid (Glutamate)FDA Link 04/2022
1	Analgesics (Analgesic Drugs)IBA 08/2021
1	LactamsIBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2020
1	SulfonamidesIBA 10/2020
1	LASSBio-448IBA 10/2020
1	Phosphodiesterase 4 InhibitorsIBA 10/2020
1	Insulin (Novolin)FDA Link 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	cyanoginosin LR (microcystin LR)IBA 01/2018
1	Therapeutic UsesIBA 02/2015
1	cylindrospermopsinIBA 02/2015
1	CollagenIBA 01/2013
1	Thrombin FDA Link 01/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2013
1	Thalidomide (Thalomid)FDA Link 01/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2012

Therapy/Procedure

1	Oral Administration 08/2021
1	Therapeutics 12/2020
1	Aftercare (After-Treatment) 01/2012